BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng L, Lv GC, Sheng J, Yang YD. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol. 2010;25:156-163. [PMID: 19780876 DOI: 10.1111/j.1440-1746.2009.05949.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Guo G, Tian X, Hu S, Du K, Zhang Q, Mao J, Jia X, Chen S, Wang J, Lai S. Screening and identification of MicroRNAs expressed in perirenal adipose tissue during rabbit growth. Lipids Health Dis 2020;19:35. [PMID: 32145738 DOI: 10.1186/s12944-020-01219-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rodrigues PM, Afonso MB, Simão AL, Carvalho CC, Trindade A, Duarte A, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM, Castro RE. miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice. Cell Death Dis 2017;8:e2748. [PMID: 28406477 DOI: 10.1038/cddis.2017.172] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
3 Koturbash I, Beland FA, Pogribny IP. Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants. Expert Opin Drug Metab Toxicol 2012;8:597-606. [PMID: 22435483 DOI: 10.1517/17425255.2012.673587] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ferreira DM, Simão AL, Rodrigues CM, Castro RE. Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. FEBS J 2014;281:2503-24. [PMID: 24702768 DOI: 10.1111/febs.12806] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
5 Li D, Wang X, Lan X, Li Y, Liu L, Yi J, Li J, Sun Q, Wang Y, Li H. Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats. Mol Cell Endocrinol. 2015;402:1-12. [PMID: 25534427 DOI: 10.1016/j.mce.2014.12.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
6 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
7 Nguyen HTL, Kasapis S, Mantri N. Physicochemical Properties and Effects of Honeys on Key Biomarkers of Oxidative Stress and Cholesterol Homeostasis in HepG2 Cells. Nutrients 2021;13:E151. [PMID: 33466262 DOI: 10.3390/nu13010151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lei L, Zhou C, Yang X, Li L. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease. Clin Exp Pharmacol Physiol 2018;45:819-31. [DOI: 10.1111/1440-1681.12940] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
9 Hijona E, Hijona L, Arenas JI, Bujanda L. Inflammatory mediators of hepatic steatosis. Mediators Inflamm 2010;2010:837419. [PMID: 20300479 DOI: 10.1155/2010/837419] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
10 Mir BA, Reyer H, Komolka K, Ponsuksili S, Kühn C, Maak S. Differentially Expressed miRNA-Gene Targets Related to Intramuscular Fat in Musculus Longissimus Dorsi of Charolais × Holstein F2-Crossbred Bulls. Genes (Basel) 2020;11:E700. [PMID: 32630492 DOI: 10.3390/genes11060700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Jia N, Lin X, Ma S, Ge S, Mu S, Yang C, Shi S, Gao L, Xu J, Bo T, Zhao J. Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. Nutr Metab (Lond) 2018;15:86. [PMID: 30555521 DOI: 10.1186/s12986-018-0323-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012;142:1431-43. [PMID: 22504185 DOI: 10.1053/j.gastro.2012.04.007] [Cited by in Crossref: 201] [Cited by in F6Publishing: 197] [Article Influence: 22.3] [Reference Citation Analysis]
13 Liu XL, Cao HX, Fan JG. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. J Dig Dis. 2016;17:708-715. [PMID: 27628945 DOI: 10.1111/1751-2980.12408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
14 Arias N, Aguirre L, Fernández-Quintela A, González M, Lasa A, Miranda J, Macarulla MT, Portillo MP. MicroRNAs involved in the browning process of adipocytes. J Physiol Biochem 2016;72:509-21. [PMID: 26695012 DOI: 10.1007/s13105-015-0459-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
15 Lendvai G, Jármay K, Karácsony G, Halász T, Kovalszky I, Baghy K, Wittmann T, Schaff Z, Kiss A. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World J Gastroenterol 2014; 20(41): 15343-15350 [PMID: 25386083 DOI: 10.3748/wjg.v20.i41.15343] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
16 Gerhard GS, DiStefano JK. Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 226-234 [PMID: 25729477 DOI: 10.4254/wjh.v7.i2.226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
17 Sun B, Karin M. Inflammation and liver tumorigenesis. Front Med. 2013;7:242-254. [PMID: 23681888 DOI: 10.1007/s11684-013-0256-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
18 Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316-321. [PMID: 19913496 DOI: 10.1016/j.bbrc.2009.11.056] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 7.8] [Reference Citation Analysis]
19 Seiri P, Abi A, Soukhtanloo M. PPAR-γ: Its ligand and its regulation by microRNAs. J Cell Biochem 2019. [PMID: 30770587 DOI: 10.1002/jcb.28419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Takahashi K, Yan I, Wen HJ, Patel T. microRNAs in liver disease: from diagnostics to therapeutics. Clin Biochem 2013;46:946-52. [PMID: 23396165 DOI: 10.1016/j.clinbiochem.2013.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
21 Laguna JC, Alegret M, Roglans N. Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients 2014;6:5933-54. [PMID: 25533006 DOI: 10.3390/nu6125933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
22 Zhang H, Yang X, Xiao Y. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochemical and Biophysical Research Communications 2016;474:364-70. [DOI: 10.1016/j.bbrc.2016.04.111] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
23 Peyrou M, Ramadori P, Bourgoin L, Foti M. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Res 2012;2012:757803. [PMID: 23024649 DOI: 10.1155/2012/757803] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
24 Kida K, Nakajima M, Mohri T, Oda Y, Takagi S, Fukami T, Yokoi T. PPARα Is Regulated by miR-21 and miR-27b in Human Liver. Pharm Res 2011;28:2467-76. [DOI: 10.1007/s11095-011-0473-y] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 8.7] [Reference Citation Analysis]
25 Yu AM, Pan YZ. Noncoding microRNAs: small RNAs play a big role in regulation of ADME? Acta Pharm Sin B 2012;2:93-101. [PMID: 32154096 DOI: 10.1016/j.apsb.2012.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
26 Li MP, Hu YD, Hu XL, Zhang YJ, Yang YL, Jiang C, Tang J, Chen XP. MiRNAs and miRNA Polymorphisms Modify Drug Response. Int J Environ Res Public Health 2016;13:E1096. [PMID: 27834829 DOI: 10.3390/ijerph13111096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
27 Bhatt SP, Guleria R. Sleep apnea and fatty liver disease: The growing link and management issues. World J Respirol 2014; 4(2): 11-18 [DOI: 10.5320/wjr.v4.i2.11] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Raghuraman S, Donkin I, Versteyhe S, Barrès R, Simar D. The Emerging Role of Epigenetics in Inflammation and Immunometabolism. Trends Endocrinol Metab 2016;27:782-95. [PMID: 27444065 DOI: 10.1016/j.tem.2016.06.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 12.4] [Reference Citation Analysis]
29 Mukhopadhyay P, Das S, Ahsan MK, Otani H, Das DK. Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol. J Cell Mol Med 2012;16:2504-17. [PMID: 22050707 DOI: 10.1111/j.1582-4934.2011.01480.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
30 Siddeek B, Inoubli L, Lakhdari N, Rachel PB, Fussell KC, Schneider S, Mauduit C, Benahmed M. MicroRNAs as potential biomarkers in diseases and toxicology. Mutat Res Genet Toxicol Environ Mutagen 2014;764-765:46-57. [PMID: 24486656 DOI: 10.1016/j.mrgentox.2014.01.010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
31 Bechmann LP, Vetter D, Ishida J, Hannivoort RA, Lang UE, Kocabayoglu P, Fiel MI, Muñoz U, Patman GL, Ge F, Yakar S, Li X, Agius L, Lee YM, Zhang W, Hui KY, Televantou D, Schwartz GJ, LeRoith D, Berk PD, Nagai R, Suzuki T, Reeves HL, Friedman SL. Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol 2013;58:1000-6. [PMID: 23353867 DOI: 10.1016/j.jhep.2013.01.020] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
32 Sundrani DP, Karkhanis AR, Joshi SR. Peroxisome Proliferator-Activated Receptors (PPAR), fatty acids and microRNAs: Implications in women delivering low birth weight babies. Syst Biol Reprod Med 2021;67:24-41. [PMID: 33719831 DOI: 10.1080/19396368.2020.1858994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yu J, Peng J, Luan Z, Zheng F, Su W. MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease. Molecules 2019;24:E230. [PMID: 30634538 DOI: 10.3390/molecules24020230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
34 He Y, Chevillet JR, Liu G, Kim TK, Wang K. The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs. Br J Pharmacol 2015;172:2733-47. [PMID: 25296724 DOI: 10.1111/bph.12968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
35 Peng Y, Xiang H, Chen C, Zheng R, Chai J, Peng J, Jiang S. MiR-224 impairs adipocyte early differentiation and regulates fatty acid metabolism. Int J Biochem Cell Biol 2013;45:1585-93. [PMID: 23665235 DOI: 10.1016/j.biocel.2013.04.029] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
36 Zhang YY, Wang HB, Wang YN, Wang HC, Zhang S, Hong JY, Guo HF, Chen D, Yang Y, Zan LS. Transcriptome analysis of mRNA and microRNAs in intramuscular fat tissues of castrated and intact male Chinese Qinchuan cattle. PLoS One 2017;12:e0185961. [PMID: 29073274 DOI: 10.1371/journal.pone.0185961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
37 Hong F, Pan S, Xu P, Xue T, Wang J, Guo Y, Jia L, Qiao X, Li L, Zhai Y. Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure. Cells 2020;9:E489. [PMID: 32093272 DOI: 10.3390/cells9020489] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
38 Rajamoorthi A, Arias N, Basta J, Lee RG, Baldán Á. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate. J Lipid Res 2017;58:2127-38. [PMID: 28874443 DOI: 10.1194/jlr.M077941] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
39 Duan X, Meng Q, Wang C, Liu Z, Sun H, Huo X, Sun P, Ma X, Peng J, Liu K. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice: Effects of calycosin against NAFLD. Journal of Gastroenterology and Hepatology 2018;33:533-42. [DOI: 10.1111/jgh.13884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
40 Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int. 2014;2014:741465. [PMID: 24745023 DOI: 10.1155/2014/741465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
41 Viktorovna SE, Alekseevich NY, Yakovlevich PV, Michailovich MI. Association of Arterial Hypertension with Hepatobiliary Pathology: The Occurrence of Comorbidity and Features of Metabolic Processes. Curr Hypertens Rev 2020;16:138-47. [PMID: 31368876 DOI: 10.2174/1573402115666190801104227] [Reference Citation Analysis]
42 Fatima A, Lynn DJ, O'Boyle P, Seoighe C, Morris D. The miRNAome of the postpartum dairy cow liver in negative energy balance. BMC Genomics 2014;15:279. [PMID: 24725334 DOI: 10.1186/1471-2164-15-279] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
43 Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118 [PMID: 30271077 DOI: 10.3748/wjg.v24.i36.4104] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
44 Nie YQ, Cao J, Zhou YJ, Liang X, Du YL, Wan YJ, Li YY. The effect of miRNA-122 in regulating fat deposition in a cell line model. J Cell Biochem. 2014;115:839-846. [PMID: 24288170 DOI: 10.1002/jcb.24725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
45 Huang J, Wang S, Feng X, Liu X, Zhao J, Zheng Q, Wei X, Ma Y. miRNA transcriptome comparison between muscle and adipose tissues indicates potential miRNAs associated with intramuscular fat in Chinese swamp buffalo. Genome 2019;62:729-38. [PMID: 31398299 DOI: 10.1139/gen-2018-0178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
46 Fatima A, Waters S, O'Boyle P, Seoighe C, Morris DG. Alterations in hepatic miRNA expression during negative energy balance in postpartum dairy cattle. BMC Genomics. 2014;15:28. [PMID: 24428929 DOI: 10.1186/1471-2164-15-28] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
47 Sun C, Fan JG, Qiao L. Potential epigenetic mechanism in non-alcoholic Fatty liver disease. Int J Mol Sci. 2015;16:5161-5179. [PMID: 25751727 DOI: 10.3390/ijms16035161] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
48 Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017;13:36-49. [PMID: 27636730 DOI: 10.1038/nrendo.2016.135] [Cited by in Crossref: 276] [Cited by in F6Publishing: 256] [Article Influence: 55.2] [Reference Citation Analysis]
49 Bechmann LP, Canbay A. The hunt for treatment options of fatty liver continues: effects of retinoic acid on hepatic steatosis reveal novel transcriptional interactions of nuclear receptors. Hepatology 2014;59:1662-4. [PMID: 24122898 DOI: 10.1002/hep.26896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Pogribny IP, Beland FA. Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease. Expert Opin Drug Metab Toxicol 2013;9:713-24. [PMID: 23565851 DOI: 10.1517/17425255.2013.783817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
51 Fu S, Zhao Y, Li Y, Li G, Chen Y, Li Z, Sun G, Li H, Kang X, Yan F. Characterization of miRNA transcriptome profiles related to breast muscle development and intramuscular fat deposition in chickens. J Cell Biochem 2018;119:7063-79. [PMID: 29737555 DOI: 10.1002/jcb.27024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
52 Desgagné V, Guérin R, Guay SP, Boyer M, Hutchins E, Picard S, Maréchal A, Corbin F, Keuren-Jensen KV, Arsenault BJ, Bouchard L. Human high-density lipoprotein microtranscriptome is unique and suggests an extended role in lipid metabolism. Epigenomics 2019;11:917-34. [PMID: 31144512 DOI: 10.2217/epi-2018-0161] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
53 Ramos LF, Silva CM, Pansa CC, Moraes KCM. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Rev Gastroenterol Hepatol 2021;15:25-40. [PMID: 32892668 DOI: 10.1080/17474124.2020.1820321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Peng S, Yan L, Zhang J, Wang Z, Tian M, Shen H. An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid. Journal of Pharmaceutical and Biomedical Analysis 2013;86:56-64. [DOI: 10.1016/j.jpba.2013.07.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
55 Jin W, Zhao Y, Zhai B, Li Y, Fan S, Yuan P, Sun G, Jiang R, Wang Y, Liu X, Tian Y, Kang X, Li G. Characteristics and expression profiles of circRNAs during abdominal adipose tissue development in Chinese Gushi chickens. PLoS One 2021;16:e0249288. [PMID: 33857153 DOI: 10.1371/journal.pone.0249288] [Reference Citation Analysis]
56 Qin S, Yin J, Huang K. Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells. Lipids 2016;51:797-805. [PMID: 27270405 DOI: 10.1007/s11745-016-4160-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
57 Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15079-15086 [PMID: 25386056 DOI: 10.3748/wjg.v20.i41.15079] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
58 Takahashi K, Yan I, Wen HJ, Patel T. microRNAs in liver disease: from diagnostics to therapeutics. Clin Biochem. 2013;46:946-952. [PMID: 23396165 DOI: 10.1016/j.clinbiochem] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
59 Peng Y, Yu S, Li H, Xiang H, Peng J, Jiang S. MicroRNAs: emerging roles in adipogenesis and obesity. Cell Signal. 2014;26:1888-1896. [PMID: 24844591 DOI: 10.1016/j.cellsig.2014.05.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 15.0] [Reference Citation Analysis]
60 Wu J, Nagy LE, Liangpunsakul S, Wang L. Non-coding RNA crosstalk with nuclear receptors in liver disease. Biochim Biophys Acta Mol Basis Dis 2021;1867:166083. [PMID: 33497819 DOI: 10.1016/j.bbadis.2021.166083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Munoz-garrido P, Marzioni M, Hijona E, Bujanda L, Banales JM. MicroRNAs in Liver Diseases. In: Lawrie CH, editor. MicroRNAs in Medicine. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 509-22. [DOI: 10.1002/9781118300312.ch31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Portius D, Sobolewski C, Foti M. MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers. PPAR Res 2017;2017:7058424. [PMID: 28167956 DOI: 10.1155/2017/7058424] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
63 Finch ML, Marquardt JU, Yeoh GC, Callus BA. Regulation of microRNAs and their role in liver development, regeneration and disease. Int J Biochem Cell Biol. 2014; Apr 13. [Epub ahead of print]. [PMID: 24731940 DOI: 10.1016/j.biocel.2014.04.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
64 Iravani F, Hosseini N, Mojarrad M. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Middle East J Dig Dis 2018;10:213-9. [PMID: 31049168 DOI: 10.15171/mejdd.2018.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
65 Liu Z, Wang Y, Borlak J, Tong W. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Sci Rep 2016;6:23709. [PMID: 27045805 DOI: 10.1038/srep23709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
66 Li C, Kuemmerle JF. Genetic and epigenetic regulation of intestinal fibrosis. United European Gastroenterol J 2016;4:496-505. [PMID: 27536359 DOI: 10.1177/2050640616659023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 Smolle E, Haybaeck J. Non-coding RNAs and lipid metabolism. Int J Mol Sci 2014;15:13494-513. [PMID: 25093715 DOI: 10.3390/ijms150813494] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
68 Yu AM, Tian Y, Tu MJ, Ho PY, Jilek JL. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy. Drug Metab Dispos 2016;44:308-19. [PMID: 26566807 DOI: 10.1124/dmd.115.067470] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
69 Stachowiak M, Szydlowski M, Flisikowski K, Flisikowska T, Bartz M, Schnieke A, Switonski M. Polymorphism in 3' untranslated region of the pig PPARA gene influences its transcript level and is associated with adipose tissue accumulation. J Anim Sci 2014;92:2363-71. [PMID: 24671595 DOI: 10.2527/jas.2013-7509] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
70 Lai CY, Lin CY, Hsu CC, Yeh KY, Her GM. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:844-56. [PMID: 29678641 DOI: 10.1016/j.bbalip.2018.04.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
71 Tan Y, Ge G, Pan T, Wen D, Gan J. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS One. 2014;9:e105192. [PMID: 25141008 DOI: 10.1371/journal.pone.0105192] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 13.1] [Reference Citation Analysis]
72 Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V. The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer. PPAR Res. 2012;2012:242498. [PMID: 22991505 DOI: 10.1155/2012/242498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
73 Wu X, Zou X, Chang Q, Zhang Y, Li Y, Zhang L, Huang J, Liang B. The evolutionary pattern and the regulation of stearoyl-CoA desaturase genes. Biomed Res Int 2013;2013:856521. [PMID: 24312911 DOI: 10.1155/2013/856521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
74 Liu WH, Tao KS, You N, Liu ZC, Zhang HT, Dou KF. Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells. PLoS One. 2011;6:e23311. [PMID: 21826246 DOI: 10.1371/journal.pone.0023311] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
75 Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond). 2014;126:183-194. [PMID: 24102098 DOI: 10.1042/cs20130203] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
76 Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(45): 6546-6551 [PMID: 23236228 DOI: 10.3748/wjg.v18.i45.6546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
77 Lamba V, Ghodke-Puranik Y, Guan W, Lamba JK. Identification of suitable reference genes for hepatic microRNA quantitation. BMC Res Notes 2014;7:129. [PMID: 24606728 DOI: 10.1186/1756-0500-7-129] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
78 Adams BD, Arem H, Hubal MJ, Cartmel B, Li F, Harrigan M, Sanft T, Cheng CJ, Pusztai L, Irwin ML. Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Res Treat 2018;170:55-67. [PMID: 29511965 DOI: 10.1007/s10549-018-4738-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
79 Xie J, Fang H, Liao S, Guo T, Yin P, Liu Y, Tian L, Niu J. Study on Schizochytrium sp. improving the growth performance and non-specific immunity of golden pompano (Trachinotus ovatus) while not affecting the antioxidant capacity. Fish Shellfish Immunol 2019;95:617-23. [PMID: 31622676 DOI: 10.1016/j.fsi.2019.10.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
80 Desgagné V, Bouchard L, Guérin R. microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application. Clin Chem Lab Med 2017;55:667-86. [PMID: 27987357 DOI: 10.1515/cclm-2016-0575] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
81 Koushki M, Zare M, Shabani M, Teimouri M, Hosseini H, Babaei Khorzoughi R, Meshkani R. Resveratrol Reduces Lipid Accumulation through Upregulating the Expression of MicroRNAs Regulating Fatty Acid Bet Oxidation in Liver Cells: Evidence from In-vivo and In-vitro Studies. Iran J Pharm Res 2020;19:333-40. [PMID: 33224240 DOI: 10.22037/ijpr.2019.111745.13332] [Reference Citation Analysis]
82 Lie S, Morrison JL, Williams-Wyss O, Suter CM, Humphreys DT, Ozanne SE, Zhang S, MacLaughlin SM, Kleemann DO, Walker SK, Roberts CT, McMillen IC. Impact of maternal undernutrition around the time of conception on factors regulating hepatic lipid metabolism and microRNAs in singleton and twin fetuses. Am J Physiol Endocrinol Metab 2016;310:E148-59. [PMID: 26487010 DOI: 10.1152/ajpendo.00600.2014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
83 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
84 Vickers KC, Sethupathy P, Baran-Gale J, Remaley AT. Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J Lipid Res 2013;54:1182-91. [PMID: 23505317 DOI: 10.1194/jlr.R034801] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
85 Kucher AN, Nazarenko MS, Markov AV, Koroleva IA, Barbarash OL. Variability of methylation profiles of CpG sites in microRNA genes in leukocytes and vascular tissues of patients with atherosclerosis. Biochemistry Moscow 2017;82:698-706. [DOI: 10.1134/s0006297917060062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Seidemann L, Krüger A, Kegel-Hübner V, Seehofer D, Damm G. Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis. Molecules 2021;26:1156. [PMID: 33671486 DOI: 10.3390/molecules26041156] [Reference Citation Analysis]
87 Bozaykut P, Sahin A, Karademir B, Ozer NK. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. Mechanisms of Ageing and Development 2016;157:17-29. [DOI: 10.1016/j.mad.2016.07.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
88 Klaassen CD, Lu H, Cui JY. Epigenetic regulation of drug processing genes. Toxicology Mechanisms and Methods 2011;21:312-24. [DOI: 10.3109/15376516.2011.562758] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
89 Feng C, Li D, Jiang L, Liu X, Li Q, Geng C, Sun X, Yang G, Yao X, Chen M. Citreoviridin induces triglyceride accumulation in hepatocytes through inhibiting PPAR-α in vivo and in vitro. Chem Biol Interact 2017;273:212-8. [PMID: 28645467 DOI: 10.1016/j.cbi.2017.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
90 Sun L, He X, Cao Y, Gao P, Zhang H. MicroRNAs and Energy Metabolism in Cancer Cells. In: Babashah S, editor. MicroRNAs: Key Regulators of Oncogenesis. Cham: Springer International Publishing; 2014. pp. 83-95. [DOI: 10.1007/978-3-319-03725-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Zhang L, Wu K, Bo T, Zhou L, Gao L, Zhou X, Chen W. Integrated microRNA and proteome analysis reveal a regulatory module in hepatic lipid metabolism disorders in mice with subclinical hypothyroidism. Exp Ther Med 2020;19:897-906. [PMID: 32010250 DOI: 10.3892/etm.2019.8281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Yung DE, Sykes C, Koulaouzidis A. The validity of suspected blood indicator software in capsule endoscopy: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2017;11:43-51. [DOI: 10.1080/17474124.2017.1257384] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
93 Dubois V, Eeckhoute J, Lefebvre P, Staels B. Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Invest 2017;127:1202-14. [PMID: 28368286 DOI: 10.1172/JCI88894] [Cited by in Crossref: 142] [Cited by in F6Publishing: 71] [Article Influence: 35.5] [Reference Citation Analysis]
94 Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med. 2016; Nov 23. [Epub ahead of print]. [PMID: 27889327 DOI: 10.1016/j.mam.2016.11.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
95 Shi L, Shi L, Song G, Zhang H, Hu Z, Wang C, Zhang D. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). European Journal of Pharmacology 2013;714:89-95. [DOI: 10.1016/j.ejphar.2013.06.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
96 Shah N, Nelson JE, Kowdley KV. MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol. 2013;3:231-242. [PMID: 25755505 DOI: 10.1016/j.jceh.2013.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
97 Chen Q, Qiu F, Zhou K, Matlock HG, Takahashi Y, Rajala RVS, Yang Y, Moran E, Ma JX. Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα. Diabetes 2017;66:1671-82. [PMID: 28270521 DOI: 10.2337/db16-1246] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 17.5] [Reference Citation Analysis]
98 Kaur K, Bhatia H, Datta M. MicroRNAs in hepatic pathophysiology in diabetes. World J Diabetes 2011; 2(10): 158-163 [PMID: 22013501 DOI: 10.4239/wjd.v2.i10.158] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
99 Ceccarelli S, Panera N, Gnani D, Nobili V. Dual Role of MicroRNAs in NAFLD. Int J Mol Sci. 2013;14:8437-8455. [PMID: 23594995 DOI: 10.3390/ijms14048437] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
100 Liu W, Cao H, Yan J, Huang R, Ying H. 'Micro-managers' of hepatic lipid metabolism and NAFLD. Wiley Interdiscip Rev RNA. 2015;6:581-593. [PMID: 26198708 DOI: 10.1002/wrna.1295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
101 Bladé C, Baselga-Escudero L, Salvadó MJ, Arola-Arnal A. miRNAs, polyphenols, and chronic disease. Mol Nutr Food Res 2013;57:58-70. [PMID: 23165995 DOI: 10.1002/mnfr.201200454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
102 Afonso MB, Rodrigues PM, Simão AL, Castro RE. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med 2016;5:E30. [PMID: 26950158 DOI: 10.3390/jcm5030030] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]